Intracranial Thrombolysis for Treatment of Acute stroke syndromes Introduction Intracranial thrombolysis (ICT) is a form of thrombolytic therapy in which fibrinolytic agents are utilized to dissolve clots formed in the cerebral arteries. It is one of the most effective therapies in people suffering from acute ischemic stroke. In ICT therapy, intravenous recombinant tissue plasminogen activator (rtPA) is utilized. More than 4 randomized clinical trials have been conducted by different organizations to determine the effect of ICT on stroke patients.
Saturday, August 26, 2017
Intracranial thrombolysis
Intracranial Thrombolysis for Treatment of Acute stroke syndromes Introduction Intracranial thrombolysis (ICT) is a form of thrombolytic therapy in which fibrinolytic agents are utilized to dissolve clots formed in the cerebral arteries. It is one of the most effective therapies in people suffering from acute ischemic stroke. In ICT therapy, intravenous recombinant tissue plasminogen activator (rtPA) is utilized. More than 4 randomized clinical trials have been conducted by different organizations to determine the effect of ICT on stroke patients.
Historical and Medical Overview
Huntington’s Disease; Historical and Medical Overview Huntington’s disease is a genetic neurological disorder involving abnormal body movements and a lack of coordination. Additionally it had mental and behavioural affects. This disease was one of the first inherited genetic disorders on which an accurate test can be performed as the gene for HD was discovered in 1993 (Thomson, A. , 1993). Originally individuals with Huntington’s were diagnosed with alcoholism or manic depression, most deaths in the early 20th century were due to starvation or dehydration as individuals were misdiagnosed.
Subscribe to:
Posts (Atom)